Bank Of Montreal Gilead Sciences, Inc. Transaction History

Bank Of Montreal

$214 Billion
Q3 2024

A detailed history of Bank Of Montreal transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 3,377,072 shares of GILD stock, worth $317 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

3,377,072

Previous 4,347,752 22.33%

Holding current value

$317 Million

Previous $298 Million 5.11%

% of portfolio

0.13%

Previous 0.15%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $64.6 Million - $81.5 Million	-970,680 Reduced 22.33%	3,377,072 $283 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $47.6 Million - $54.9 Million	753,545 Added 20.97%	4,347,752 $298 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $77.2 Million - $94.1 Million	-1,077,840 Reduced 23.07%	3,594,207 $263 Million
Q4 2023 Feb 08, 2024	BUY	$73.27 - $83.09 $140 Million - $158 Million	1,907,119 Added 68.98%	4,672,047 $378 Million
Q3 2023 Nov 01, 2023	BUY	$73.94 - $80.67 $21.7 Million - $23.7 Million	293,746 Added 11.89%	2,764,928 $207 Million
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $17 Million - $19.3 Million	223,159 Added 9.93%	2,471,182 $190 Million
Q1 2023 Jun 13, 2024	SELL	$77.31 - $88.08 $133 Million - $151 Million	-1,719,812 Reduced 47.85%	1,874,395 $156 Million
Q4 2022 Feb 01, 2023	BUY	$62.32 - $89.47 $34.8 Million - $49.9 Million	558,176 Added 33.03%	2,248,023 $193 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $46.4 Million - $53 Million	-779,075 Reduced 31.56%	1,689,847 $144 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $31.6 Million - $35.5 Million	-546,664 Reduced 18.13%	2,468,922 $210 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $77.2 Million - $96.7 Million	-1,332,656 Reduced 30.65%	3,015,586 $256 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $60 Million - $68.1 Million	924,201 Added 26.99%	4,348,242 $370 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $24.4 Million - $26.3 Million	-359,947 Reduced 9.51%	3,424,041 $291 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $240 Million - $262 Million	3,783,988 New	3,783,988 $322 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account